Viewing Study NCT02453620


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-04-24 @ 6:59 PM
Study NCT ID: NCT02453620
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2015-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage III Breast Cancer AJCC v8 View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Breast Adenocarcinoma View
None Invasive Breast Carcinoma View
None Malignant Solid Neoplasm View
Keywords: